Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids

Pyrazinamide, the first-line antitubercular drug, has been regarded the basic component of tuberculosis treatment for over sixty years. Researchers have investigated its effect on Mycobacterium tuberculosis for this long time, and as a result, new potential targets of pyrazinamide or its active form...

Descripción completa

Detalles Bibliográficos
Autores principales: Semelková, Lucia, Janošcová, Petra, Fernandes, Carlos, Bouz, Ghada, Janďourek, Ondřej, Konečná, Klára, Paterová, Pavla, Navrátilová, Lucie, Kuneš, Jiří, Doležal, Martin, Zitko, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151461/
https://www.ncbi.nlm.nih.gov/pubmed/28880230
http://dx.doi.org/10.3390/molecules22091491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151461/
https://www.ncbi.nlm.nih.gov/pubmed/28880230
http://dx.doi.org/10.3390/molecules22091491

Ejemplares similares